CanaFarma Hemp Products Corp. operates in the hemp industry that offers a range of hemp-related products and services. More Details
Flawless balance sheet with weak fundamentals.
Share Price & News
How has CanaFarma Hemp Products's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: CNFA is more volatile than 75% of Canadian stocks over the past 3 months, typically moving +/- 17% a week.
Volatility Over Time: CNFA's weekly volatility has decreased from 52% to 17% over the past year, but is still higher than 75% of Canadian stocks.
7 Day Return
1 Year Return
Return vs Industry: Insufficient data to determine how CNFA performed against the Canadian Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how CNFA performed against the Canadian Market.
Long-Term Price Volatility Vs. Market
How volatile is CanaFarma Hemp Products's share price compared to the market and industry in the last 5 years?
Simply Wall St News
No news available
Is CanaFarma Hemp Products undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate CNFA's fair value to establish if it is undervalued.
Significantly Below Fair Value: Insufficient data to calculate CNFA's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: CNFA is unprofitable, so we can't compare its PE Ratio to the CA Pharmaceuticals industry average.
PE vs Market: CNFA is unprofitable, so we can't compare its PE Ratio to the Canadian market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate CNFA's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: CNFA is overvalued based on its PB Ratio (7.7x) compared to the CA Pharmaceuticals industry average (1.5x).
How is CanaFarma Hemp Products forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Pharmaceuticals & Biotech industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as CanaFarma Hemp Products has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
- Examine CanaFarma Hemp Products's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
- CanaFarma Hemp Products competitive advantages and company strategy can generally be found in its financial reports archived here.
- Explore growth companies in the Pharmaceuticals & Biotech industry.
How has CanaFarma Hemp Products performed over the past 5 years?
Historical Pharmaceuticals & Biotech annual earnings growth
Earnings and Revenue History
Quality Earnings: CNFA is currently unprofitable.
Growing Profit Margin: CNFA is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: Unable to establish if CNFA's year-on-year earnings growth rate was positive over the past 5 years as it has been trading publicly for less than 3 years.
Accelerating Growth: Unable to compare CNFA's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: CNFA is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (-45%).
Return on Equity
High ROE: CNFA has a negative Return on Equity (-83.46%), as it is currently unprofitable.
How is CanaFarma Hemp Products's financial position?
Financial Position Analysis
Short Term Liabilities: CNFA's short term assets ($3.9M) exceed its short term liabilities ($484.7K).
Long Term Liabilities: CNFA has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: CNFA is debt free.
Reducing Debt: CNFA has not had any debt for past 5 years.
Debt Coverage: CNFA has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: CNFA has no debt, therefore coverage of interest payments is not a concern.
What is CanaFarma Hemp Products's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate CNFA's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate CNFA's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if CNFA's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if CNFA's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of CNFA's dividend in 3 years as they are not forecast to pay a notable one for the Canadian market.
How experienced are the management team and are they aligned to shareholders interests?
David Lonsdale (66 yo)
Mr. David Martin Lonsdale serves as Chief Executive Officer of CanaFarma Hemp Products Corp. Mr. Lonsdale is a Director at Buchans Wileys Exploration Inc. He serves as CEO of Buchans Wileys Exploration Inc...
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: CNFA only recently listed within the past 12 months.
CanaFarma Hemp Products Corp.'s company bio, employee growth, exchange listings and data sources
- Name: CanaFarma Hemp Products Corp.
- Ticker: CNFA
- Exchange: CNSX
- Industry: Pharmaceuticals
- Sector: Pharmaceuticals & Biotech
- Market Cap: CA$70.439m
- Shares outstanding: 195.66m
- Website: https://www.canafarmacorp.com
- CanaFarma Hemp Products Corp.
- 2080-777 Hornby Street
- British Columbia
- V6Z 1S4
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|CNFA||CNSX (Canadian National Stock Exchange)||Yes||Common Shares||CA||CAD||Mar 2020|
|4K9||DB (Deutsche Boerse AG)||Yes||Common Shares||DE||EUR||Mar 2020|
CanaFarma Hemp Products Corp. operates in the hemp industry that offers a range of hemp-related products and services. It provides hemp-processing services and hemp-based products. The company is based in ...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/11/27 01:03|
|End of Day Share Price||2020/11/26 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.